Why the study?
As TAVR volume increases with evolving indications, insight is needed regarding procedure access and outcomes to evaluate potential racial disparities in the contemporary era.
Does non-White race affect in-hospital mortality and composite outcomes in patients undergoing TAVR?
Population
42,877 TAVR patients aged ≥18 in the National Inpatient Sample (2016–2019)
Comparison
White vs non-White patients
Design
Retrospective propensity-score matched nationwide registry study
Follow-up
In-hospital
Authors
Loading...
No difference in TAVR mortality or composite outcome by race; leaves open drivers of higher complication rates in non-White patients.
Does non-White race affect in-hospital mortality and composite outcomes in patients undergoing TAVR?
TAVR remains safe with comparable in-hospital mortality between White and non-White patients, though non-White patients experience higher rates of specific complications such as acute renal failure and vascular complications.
Sun et al. (2026) studied this question.